|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
KIMMEL ROGER H C/O ROTHSCHILD INC. 1251 AVENUE OF THE AMERICAS NEW YORK, NY 10022 |
X |
/s/ Caroline B. Manogue, by Power of Attorney | 10/09/2012 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Pursuant to the Endo Health Solutions Directors Stock Election Plan, on December 15, 2011, Mr. Kimmel elected to receive 100% of his 2012 cash retainer fees and 100% of his Chairman fees in Endo common stock. At the time that the retainer and Chairman fees would otherwise have been payable, the number of shares of Endo common stock are fixed and are reported as of such date on Table I as an acquisition of securities. These cash retainer and Chairman fees are payable to Mr. Kimmel in consideration of his services on the Endo Health Solutions Inc. Board of Directors for the third quarter 2012. Under the Endo Health Solutions Deferred Compensation Plan, also on December 15, 2011, Mr. Kimmel elected to defer receipt of all of these shares. |
(2) | This number represents (i) 167,500 shares of common stock held in trusts for which Mr. Kimmel serves as trustee and as to which shares Mr. Kimmel holds either the sole or the shared power of disposition and power to vote, (ii) 19,704 shares of restricted stock, all of which were fully vested and have been deferred under the Endo Health Solutions Directors Deferred Compensation Plan, (iii) 5,481 restricted stock units and (iv) 16,115 shares of common stock, of which 9,593 have been deferred under the Endo Health Solutions Directors Deferred Compensation Plan. |
Remarks: This Form 4/A amends and replaces in its entirety the original Form 4 filed by the Reporting Person on October 2, 2012 and is being filed to correct an inadvertent clerical error in Table I and corresponding footnote with respect to the "Amount of Securities Beneficially Owned Following Reported Transactions". |